Company profile
Ablynx company profile
Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies®, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious human diseases, including inflammation, haematology, oncology and pulmonary disease. Today, the Company has approximately 25 projects in the pipeline and five Nanobodies in clinical development.
Business identity
- Website
- http://www.ablynx.com
- Contact email
- [email protected]
- Phone number
- (092) 620-000_
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00251-00500 employees
- Revenue range
- $50K+
- Founded
- 2001-01-01
Headquarters
- Headquarters
- Zwijnaarde, Oost-Vlaanderen, Belgium
- Postal code
- 9052
- Country code
- BE
- Continent
- Europe